Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Polyelectrolyte multilayered nanoparticles: using nanolayers for controlled and targeted systemic release.

Hammond PT.

Nanomedicine (Lond). 2012 May;7(5):619-22. doi: 10.2217/nnm.12.47. No abstract available.

2.

Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers.

Lee SH, Bae KH, Kim SH, Lee KR, Park TG.

Int J Pharm. 2008 Nov 19;364(1):94-101. doi: 10.1016/j.ijpharm.2008.07.027. Epub 2008 Aug 3.

PMID:
18723087
3.

[Types of non-viral delivery systems of small interfering RNA].

Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu.

Mol Biol (Mosk). 2012 May-Jun;46(3):387-401. Review. Russian.

PMID:
22888629
4.
5.

Polymeric carrier systems for siRNA delivery.

Vader P, van der Aa LJ, Storm G, Schiffelers RM, Engbersen JF.

Curr Top Med Chem. 2012;12(2):108-19. Review.

PMID:
22196278
6.

[Therapeutic siRNAs and non-viral systems for their delivery].

Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu.

Mol Biol (Mosk). 2012 May-Jun;46(3):371-86. Review. Russian.

PMID:
22888628
7.
8.

Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach.

Tack F, Noppe M, Van Dijck A, Dekeyzer N, Van Der Leede BJ, Bakker A, Wouters W, Janicot M, Brewster ME.

Pharmazie. 2008 Mar;63(3):221-5.

PMID:
18444511
9.

RNAi therapeutics: the teenage years.

Perkel JM.

Biotechniques. 2012 Jun;52(6):355-7. doi: 10.2144/000113871. No abstract available.

10.

Nanoparticles for intracellular-targeted drug delivery.

Paulo CS, Pires das Neves R, Ferreira LS.

Nanotechnology. 2011 Dec 9;22(49):494002. doi: 10.1088/0957-4484/22/49/494002. Epub 2011 Nov 21. Review.

PMID:
22101232
11.

Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.

Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5715-21. Epub 2007 Mar 22.

12.

Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic?

Riviere JE.

Nanomedicine (Lond). 2013 Sep;8(9):1357-9. doi: 10.2217/nnm.13.129. No abstract available.

13.

Antibody-mediated delivery of siRNAs for anti-HIV therapy.

Kim SS, Subramanya S, Peer D, Shimaoka M, Shankar P.

Methods Mol Biol. 2011;721:339-53. doi: 10.1007/978-1-61779-037-9_21.

PMID:
21431696
14.

PAMAM dendrimers for efficient siRNA delivery and potent gene silencing.

Zhou J, Wu J, Hafdi N, Behr JP, Erbacher P, Peng L.

Chem Commun (Camb). 2006 Jun 14;(22):2362-4. Epub 2006 May 10.

PMID:
16733580
15.

Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.

Powell AC, Paciotti GF, Libutti SK.

Methods Mol Biol. 2010;624:375-84. doi: 10.1007/978-1-60761-609-2_25. Review.

PMID:
20217609
16.

Nanoparticles: a promising modality in the treatment of sarcomas.

Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z.

Pharm Res. 2011 Feb;28(2):260-72. doi: 10.1007/s11095-010-0173-z. Epub 2010 May 27. Review.

PMID:
20505985
17.

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.

Lin D, Cheng Q, Jiang Q, Huang Y, Yang Z, Han S, Zhao Y, Guo S, Liang Z, Dong A.

Nanoscale. 2013 May 21;5(10):4291-301. doi: 10.1039/c3nr00294b.

PMID:
23552843
18.

Negligible absorption of radiofrequency radiation by colloidal gold nanoparticles.

Li D, Jung YS, Tan S, Kim HK, Chory E, Geller DA.

J Colloid Interface Sci. 2011 Jun 1;358(1):47-53. doi: 10.1016/j.jcis.2011.01.059. Epub 2011 Jan 22.

PMID:
21429501
19.

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.

Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.

PMID:
22979990
20.

Targeted delivery systems of small interfering RNA by systemic administration.

Kawakami S, Hashida M.

Drug Metab Pharmacokinet. 2007 Jun;22(3):142-51. Review.

Supplemental Content

Support Center